0
0
1/1/24 at 5:34am
Organization
Medical Dialogues
Author
Dr. Nandita Mohan
45 words
0
Comments
Global pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GM™ Forte are fixed-dose combination (FDC)
You are the first to view
https://medicaldialogues.in/md-brand-connect/lupin-launches-dapaturn-gm-range-for-improved-approach-to-manage-type-2-diabetes-122372
Create an account
or login to join the discussion